Price range: $120.00 through $225.00
GLP-3
Research-use-only next-gen triple agonist GLP peptide engaging GLP-1, GIP, and Glucagon pathways. Studied in bioenergetic models of appetite, glucose handling, and multi-receptor metabolic signaling.
GLP-3 is a research-use-only, triple agonist incretin-pathway analog engaging GLP-1 + GIP + Glucagon receptors. Investigations probe multi-receptor signaling integration, mitochondrial efficiency, and redox-sensitive responses in vitro. Not intended for diagnostic or therapeutic use.
Latest Certificate of Analysis.
View COA history.
| Name | GLP-3 Research Analog (Triple GLP-1 + GIP + Glucagon Agonist) |
| Synonyms | Triple incretin/glucagon analog | GLP-1/GIP/GCGR co-agonist |
| Sequence | 39-aa peptide with lipidation; KEGG motif: YXQGTFTSDY SILLDKKAQX AFIEYLLEGG PSSGAPPPS (X = non-canonical residue) |
| Molecular Formula | C221H342N46O68 |
| Molecular Weight | ≈4731.34 g/mol (free base) |
| CAS Number | 2381089-83-2 |
| Appearance | White to off-white lyophilized powder |
| Solubility | Soluble in sterile water or bacteriostatic water |
| Purity | ≥99% (HPLC) |
| Storage Guidelines | • Lyophilized: ≤0°F (–18°C), dry, protected from light • Reconstituted: 36–46°F (2–8°C); avoid repeat freeze–thaw • Long-Term: Keep dry and frozen until use |
Bioenergetic peptides are used in RUO studies to explore how cells generate, manage, and recover energy. These compounds interact with key metabolic pathways—especially mitochondrial ATP output and redox signaling—making them essential tools for researchers investigating energy dysfunction, oxidative stress, and cell viability under stress conditions.
Exciting Areas of Study
This product is intended solely for laboratory research purposes. It is not suitable for human, animal, or household use. Researchers must follow institutional safety protocols. See our Terms & Conditions and our Research Compliance Disclaimers for details.
| Select Strength (MG) | 10MG, 20MG, 30MG, 40MG |
|---|
| Lot number | Analysis date | Testing | Certificate |
|---|---|---|---|
| LBL-1125-BBG70-1041 | February 27, 2026 | Purity & Net Peptide Testing | View PDF |
| LBL-0625-BBG70-1041 | July 17, 2025 | Purity & Net Peptide Testing | View PDF |
| LBL-1125-BBG70-1041 | February 27, 2026 | Endotoxin (LPS) Testing | View PDF |
| LBL-1125-BBG70-0025 | April 23, 2026 | View PDF | |
| LBL-0326-BBG70-0056 | May 12, 2026 | Purity & Net Peptide Testing | View PDF |
Reviews
There are no reviews yet.